Meridian Bncp Cmn (EBSB) 15.45 $EBSB Meridian Bancorp,

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Meridian Bncp Cmn (EBSB) 15.45 $EBSB

Meridian Bancorp, Inc. Announces Quarterly Dividend
GlobeNewswire - Wed Jun 01, 3:05PM CDT
The Board of Directors of Meridian Bancorp, Inc. (the "Company" (NASDAQ:EBSB), the holding company for East Boston Savings Bank, today declared a quarterly cash dividend of $0.03 per common share, payable on July 1, 2016 to stockholders of record at the close of business on June 17, 2016.
EBSB: 15.45 (-0.17)

Meridian Bancorp, Inc. Reports Net Income for the First Quarter Ended March 31, 2016
GlobeNewswire - Tue Apr 26, 3:05PM CDT
Meridian Bancorp, Inc. (the "Company" or "Meridian" (NASDAQ:EBSB), the holding company for East Boston Savings Bank (the "Bank" announced net income of $7.5 million, or $0.14 per diluted share, for the quarter ended March 31, 2016, up from $6.9 million, or $0.13 per diluted share, for the quarter ended December 31, 2015 and $6.4 million, or $0.12 per diluted share, for the quarter ended March 31, 2015. The Company's return on average assets was 0.83% for the quarter ended March 31, 2016, up from 0.80% for the quarter ended December 31, 2015 and 0.78% for the quarter ended March 31, 2015. For the quarter ended March 31, 2016, the Company's return on average equity was 5.11%, up from 4.67% for the quarter ended December 31, 2015 and 4.41% for the quarter ended March 31, 2015.
EBSB: 15.45 (-0.17)

Meridian Bancorp posts 4Q profit
Automated Insights - Tue Jan 26, 5:19PM CST
PEABODY, Mass. (AP) _ Meridian Bancorp Inc. (EBSB) on Tuesday reported fourth-quarter profit of $6.9 million.
EBSB: 15.45 (-0.17)

Meridian Bancorp, Inc. Reports Net Income for the Fourth Quarter and Year Ended December 31, 2015
GlobeNewswire - Tue Jan 26, 3:05PM CST
Meridian Bancorp, Inc. (the "Company" or "Meridian" (NASDAQ:EBSB), the holding company for East Boston Savings Bank (the "Bank" announced net income of $6.9 million, or $0.13 per diluted share, for the quarter ended December 31, 2015 compared to $6.0 million, or $0.11 per diluted share, for the quarter ended December 31, 2014. For the year ended December 31, 2015, net income was $24.6 million, or $0.46 per diluted share compared to $22.3 million, or $0.42 per diluted share, for the year ended December 31, 2014. The Company's return on average assets was 0.80% for the quarter ended December 31, 2015 compared to 0.75% for the quarter ended December 31, 2014. For the year ended December 31, 2015, the Company's return on average assets was 0.74% compared to 0.75% for the year ended December 31, 2014. The Company's return on average equity was 4.67% for the quarter ended December 31, 2015 compared to 4.19% for the quarter ended December 31, 2014. For the year ended December 31, 2015, the Company's return on average equity was 4.19%, down from 5.69% for the year ended December 31, 2014, reflecting the net cash proceeds of $302.3 million raised in the Company's second step common stock offering completed on July 28, 2014.
EBSB: 15.45 (-0.17)

Meridian Bancorp, Inc. Reports Net Income for the Third Quarter and Nine Months Ended September 30, 2015
GlobeNewswire - Tue Oct 27, 3:07PM CDT
Meridian Bancorp, Inc. (the "Company" or "Meridian" (NASDAQ:EBSB), the holding company for East Boston Savings Bank (the "Bank" announced net income of $5.7 million, or $0.11 per diluted share, for the quarter ended September 30, 2015 compared to $6.0 million, or $0.11 per diluted share, for the quarter ended September 30, 2014. For the nine months ended September 30, 2015, net income was $17.7 million, or $0.33 per diluted share compared to $16.3 million, or $0.30 per diluted share, for the nine months ended September 30, 2014. The Company's return on average assets was 0.68% for the quarter ended September 30, 2015 compared to 0.76% for the quarter ended September 30, 2014. For the nine months ended September 30, 2015, the Company's return on average assets was 0.71% compared to 0.75% for the nine months ended September 30, 2014. The Company's return on average equity was 3.89% for the quarter ended September 30, 2015 compared to 5.02% for the quarter ended September 30, 2014. For the nine months ended September 30, 2015, the Company's return on average equity was 4.03% compared to 6.57% for the nine months ended September 30, 2014. The decreases in return on average equity reflect the net cash proceeds of $302.3 million raised in the Company's second step common stock offering completed on July 28, 2014. As a result of the Company's second-step common stock offering, all historical share and per share information has been restated to reflect the 2.4484-to-one exchange ratio.
EBSB: 15.45 (-0.17)

BUYINS.NET: EBSB SqueezeTrigger Price is $13.20. There is $33,135,964 That Short Sellers Still Need To Cover.
M2 - Mon Sep 21, 10:36AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring Meridian Interstate Bancorp Inc (NASDAQ:EBSB) in real time and just received an alert that EBSB is crossing above its primary SqueezeTrigger Price, the price that a short squeeze can start in any stock. There are 2508400 shares that have been shorted at the volume weighted average SqueezeTrigger Price of $13.20. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com .
EBSB: 15.45 (-0.17)

BUYINS.NET: EBSB SqueezeTrigger Price is $13.22. There is $18,597,896 That Short Sellers Still Need To Cover.
M2 - Fri Jul 24, 10:37AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring Meridian Interstate Bancorp Inc (NASDAQ:EBSB) in real time and just received an alert that EBSB is crossing above its primary SqueezeTrigger Price, the price that a short squeeze can start in any stock. There are 1406800 shares that have been shorted at the volume weighted average SqueezeTrigger Price of $13.22. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com .
EBSB: 15.45 (-0.17)

BUYINS.NET: EBSB SqueezeTrigger Price is $13.21. There is $13,679,568 That Short Sellers Still Need To Cover.
M2 - Tue Jun 30, 11:34AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring Meridian Interstate Bancorp Inc (NASDAQ:EBSB) in real time and just received an alert that EBSB is crossing above its primary SqueezeTrigger Price, the price that a short squeeze can start in any stock. There are 1033200 shares that have been shorted at the volume weighted average SqueezeTrigger Price of $13.21. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com .
EBSB: 15.45 (-0.17)

BUYINS.NET: EBSB SqueezeTrigger Price is $13.21. There is $13,669,236 That Short Sellers Still Need To Cover.
M2 - Thu Jun 25, 2:52AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring Meridian Interstate Bancorp Inc (NASDAQ:EBSB) in real time and just received an alert that EBSB is crossing above its primary SqueezeTrigger Price, the price that a short squeeze can start in any stock. There are 1033200 shares that have been shorted at the volume weighted average SqueezeTrigger Price of $13.21. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com .
EBSB: 15.45 (-0.17)

Meridian Bancorp (EBSB): Strong Industry, Solid Earnings Estimate Revisions - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue May 12, 7:42AM CDT
Meridian Bancorp is seeing solid earnings estimate revision activity and is in great company from a Zacks Industry Rank perspective
EBSB: 15.45 (-0.17)

People's United Q1 Earnings Beat, Loan & Deposits Grow - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 16, 9:55AM CDT
People's United's (PBCT) first-quarter 2015 operating earnings of 21 cents per share beat the Zacks Consensus Estimate by a penny.
PBCT: 16.14 (-0.11), BFIN: 12.35 (+0.01), DCOM: 17.59 (-0.07), EBSB: 15.45 (-0.17)

BUYINS.NET: EBSB SqueezeTrigger Price is $13.23. There is $12,286,656 That Short Sellers Still Need To Cover.
M2 - Tue Mar 31, 4:26AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring Meridian Interstate Bancorp Inc (NASDAQ:EBSB) in real time and just received an alert that EBSB is crossing above its primary SqueezeTrigger Price, the price that a short squeeze can start in any stock. There are 925200 shares that have been shorted at the volume weighted average SqueezeTrigger Price of $13.23. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com .
EBSB: 15.45 (-0.17)

Banner Corp. Hits 52-Week High on Siuslaw Acquisition - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 17, 1:35PM CDT
Shares of WA-based Banner Corporation (BANR) achieved a new 52-week high of $45.93 as the markets opened on Mar 16. The stock closed a notch lower at $45.42, reflecting a decent return of 12.6% over the past one year. The trading volume for the session was 61,000 shares.
PROV: 19.17 (+0.07), BANR: 43.64 (-0.64), EBSB: 15.45 (-0.17), ANCB: 25.36 (-0.64)

Will JPMorgan Overcome Legal Issues & Exhibit Growth? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 04, 1:41PM CST
On Feb 27, 2015, we issued an updated research report on JPMorgan (JPM).
SFST: 28.06 (-0.28), JPM: 67.09 (-0.41), WF: 28.99 (+0.32), EBSB: 15.45 (-0.17)

BofA Ends Legal War Over Fontainebleau, to Pay $300M - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 26, 4:15PM CST
BofA (BAC) has settled its lawsuit related to Fontainebleau Las Vegas, LLC by agreeing to reimburse $300 million, as disclosed by the bank in its regulatory filing yesterday.
CG: 15.32 (-0.17), PROV: 19.17 (+0.07), EBSB: 15.45 (-0.17), BAC: 15.87 (-0.27)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 146

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 72

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 626

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 168

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 189

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 334

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 42

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 92

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 356

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 570

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading

Top 5 Most Recently Viewed Articles

Jade Power Trust Celebrates Success at Annual and Special Meeting

Updated Category News Views 190

Jade Power Trust's Annual Meeting Highlights Jade Power Trust (TSXV: JPWR.H) recently concluded its Annual and Special Meeting of unitholders, where significant decisions were made to shape the future of the Trust. The meeting, organized with great attention and resources, took place with a focus on transparency and community engagement. Re-election of Board Members...

Continue Reading
Vesper Bio's Breakthrough Phase I Results for FTD Treatment

Updated Category News Views 112

Vesper Bio Reports Positive Results from Phase I Study Vesper Bio ApS, a biotech company in the clinical stage known for its advancements in sortilin receptor biology, has made significant strides with its lead candidate, VES001. This groundbreaking compound is emerging as a potentially disease-modifying treatment for patients diagnosed with frontotemporal dementia (FTD),...

Continue Reading
Texas Pacific Land Trust Achieves Record Stock Performance

Updated Category News Views 103

Texas Pacific Land Trust Reaches New Heights In a significant display of market strength, Texas Pacific Land Trust (NYSE: TPL) stock has soared to an extraordinary all-time high of $996.82. This remarkable feat highlights a period of impressive growth for the company, as its stock has demonstrated a stunning 63.04% increase over the past year. Investors are exhibiting...

Continue Reading
Headwall Photonics Partners with NV5 to Enhance ENVI Software

Updated Category News Views 77

Headwall Photonics scored a major win back in 2024, announcing a strategic partnership with NV5 that aimed to shake up the hyperspectral imaging landscape. The deal wasn’t just about another tech tie-up; it was about embedding NV5's renowned ENVI software into Headwall's offerings, which could change how users handle geospatial data. ENVI Software Integration: What’s...

Continue Reading
DZS Inc. Completes Strategic Asset Sale to AXON Networks

Updated Category News Views 222

DZS Inc. Completes Strategic Asset Sale DZS Inc. (OTC: DZSI), known for its advanced network edge, connectivity, and cloud edge software solutions, has successfully completed the sale of its service assurance and WiFi management software portfolio to AXON Networks. This transaction includes key products such as Expresse, CloudCheck, and TruSpeed, along with their...

Continue Reading